US Stock MarketDetailed Quotes

BSX Boston Scientific

Watchlist
  • 90.450
  • +3.460+3.98%
Close Nov 18 16:00 ET
  • 90.540
  • +0.090+0.10%
Pre 04:22 ET
133.31BMarket Cap74.75P/E (TTM)

Boston Scientific Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
50.34%875M
21.86%942M
-14.66%163M
63.98%2.5B
18.71%958M
23.31%582M
151.79%773M
423.73%191M
-18.39%1.53B
68.48%807M
Net income from continuing operations
-6.94%469M
19.26%322M
57.01%493M
128.08%1.59B
260.00%504M
168.09%504M
3.85%270M
185.45%314M
-32.95%698M
47.37%140M
Operating gains losses
7.69%14M
1,000.00%44M
-93.55%2M
-72.81%59M
147.83%11M
30.00%13M
-75.00%4M
-85.51%31M
166.16%217M
68.06%-23M
Depreciation and amortization
2.00%306M
4.36%311M
6.67%304M
5.28%1.2B
6.46%313M
5.63%300M
4.93%298M
4.01%285M
3.93%1.14B
1.38%294M
Deferred tax
62.07%-11M
84.38%-10M
63.16%31M
98.41%-1M
942.86%73M
-226.09%-29M
-255.56%-64M
125.33%19M
49.19%-63M
109.33%7M
Other non cash items
-15.60%119M
-70.59%-116M
55.56%14M
-28.80%136M
--54M
63.95%141M
-221.43%-68M
-81.63%9M
864.00%191M
--0
Change In working capital
194.32%166M
-1,392.86%-209M
-42.07%-743M
23.38%-770M
-117.07%-57M
42.11%-176M
96.03%-14M
23.31%-523M
-186.32%-1.01B
1,054.29%334M
-Change in receivables
-1,000.00%-33M
-52.00%-114M
-32.56%-114M
-8.18%-238M
-68.18%-74M
78.57%-3M
21.88%-75M
-30.30%-86M
21.15%-220M
70.27%-44M
-Change in inventory
72.77%-55M
55.61%-95M
32.97%-124M
-105.61%-660M
-28.26%-59M
-112.63%-202M
-197.22%-214M
-71.30%-185M
7.23%-321M
-48.39%-46M
-Change in payables and accrued expense
1,294.12%237M
-75.43%71M
-113.27%-450M
146.27%118M
-93.13%23M
112.06%17M
456.79%289M
42.66%-211M
-162.50%-255M
151.88%335M
-Change in other current assets
41.67%17M
-407.14%-71M
-34.15%-55M
104.78%10M
-40.45%53M
122.22%12M
86.54%-14M
70.71%-41M
-55.97%-209M
709.09%89M
Cash from discontinued investing activities
Operating cash flow
43.55%1B
23.56%813M
-13.68%164M
64.02%2.5B
18.59%957M
48.51%698M
114.33%658M
427.59%190M
-18.40%1.53B
68.83%807M
Investing cash flow
Cash flow from continuing investing activities
-620.20%-1.43B
67.62%-272M
41.32%-284M
-28.05%-2.58B
-478.57%-1.05B
11.21%-198M
-2,609.68%-840M
69.27%-484M
-26.00%-2.01B
60.52%-182M
Net PPE purchase and sale
5.29%-179M
-8.39%-155M
-64.81%-178M
-22.74%-707M
-27.14%-267M
-26.85%-189M
-37.50%-143M
4.42%-108M
-6.67%-576M
19.85%-210M
Net intangibles purchase and sale
-1,233.33%-120M
-23.21%-69M
-5,800.00%-59M
-228.26%-59M
-69.57%7M
-200.00%-9M
-429.41%-56M
-111.11%-1M
-87.26%46M
-92.31%23M
Net business purchase and sale
---1.13B
92.53%-48M
87.47%-47M
-17.83%-1.81B
-15,960.00%-793M
--0
---643M
74.51%-375M
-7.33%-1.54B
102.28%5M
Net investment purchase and sale
--0
----
----
-96.43%2M
--0
--0
----
----
273.33%56M
--0
Net other investing changes
----
----
---1M
--1M
--0
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-624.37%-1.43B
67.74%-271M
41.12%-285M
-28.00%-2.57B
-475.41%-1.05B
12.44%-197M
-2,796.55%-840M
69.25%-484M
-25.92%-2.01B
60.30%-183M
Financing cash flow
Cash flow from continuing financing activities
-56.25%7M
-44.19%24M
2,373.91%1.57B
100.91%5M
650.00%15M
108.00%16M
112.57%43M
-885.71%-69M
-475.79%-547M
125.00%2M
Net issuance payments of debt
153.66%22M
--0
--1.62B
97.58%-4M
--0
73.55%-41M
152.86%37M
--0
---165M
--0
Cash dividends paid
--0
--0
--0
49.09%-28M
--0
--0
0.00%-14M
0.00%-14M
0.00%-55M
0.00%-13M
Proceeds from stock option exercised by employees
27.40%93M
-4.00%24M
-84.62%2M
51.81%126M
0.00%15M
28.07%73M
400.00%25M
116.67%13M
38.33%83M
150.00%15M
Net other financing activities
-575.00%-108M
--0
27.94%-49M
78.35%-89M
--0
81.61%-16M
98.11%-5M
-17.24%-68M
-311.00%-411M
0.00%-1M
Cash from discontinued financing activities
Financing cash flow
-56.25%7M
-44.19%24M
2,373.91%1.57B
100.91%5M
1,400.00%15M
108.04%16M
112.50%43M
-1,050.00%-69M
-476.84%-548M
112.50%1M
Net cash flow
Beginning cash position
393.87%3.06B
227.13%2.5B
-6.31%1.06B
-48.06%1.13B
127.77%1.13B
35.37%620M
44.23%763M
-48.06%1.13B
8.67%2.17B
-76.98%497M
Current changes in cash
-181.04%-419M
505.00%567M
498.90%1.45B
93.51%-67M
-112.94%-81M
1,048.89%517M
-115.38%-140M
77.85%-363M
-677.09%-1.03B
6,160.00%626M
Effect of exchange rate changes
220.00%6M
66.67%-1M
---7M
55.56%-4M
33.33%4M
16.67%-5M
50.00%-3M
--0
-50.00%-9M
400.00%3M
End cash Position
134.01%2.65B
393.87%3.06B
227.13%2.5B
-6.31%1.06B
-6.31%1.06B
127.77%1.13B
35.37%620M
44.23%763M
-48.06%1.13B
-48.06%1.13B
Free cash flow
41.87%698M
29.42%585M
-217.39%-81M
86.32%1.7B
14.62%690M
64.55%492M
123.76%452M
136.51%69M
-30.55%914M
183.96%602M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 50.34%875M21.86%942M-14.66%163M63.98%2.5B18.71%958M23.31%582M151.79%773M423.73%191M-18.39%1.53B68.48%807M
Net income from continuing operations -6.94%469M19.26%322M57.01%493M128.08%1.59B260.00%504M168.09%504M3.85%270M185.45%314M-32.95%698M47.37%140M
Operating gains losses 7.69%14M1,000.00%44M-93.55%2M-72.81%59M147.83%11M30.00%13M-75.00%4M-85.51%31M166.16%217M68.06%-23M
Depreciation and amortization 2.00%306M4.36%311M6.67%304M5.28%1.2B6.46%313M5.63%300M4.93%298M4.01%285M3.93%1.14B1.38%294M
Deferred tax 62.07%-11M84.38%-10M63.16%31M98.41%-1M942.86%73M-226.09%-29M-255.56%-64M125.33%19M49.19%-63M109.33%7M
Other non cash items -15.60%119M-70.59%-116M55.56%14M-28.80%136M--54M63.95%141M-221.43%-68M-81.63%9M864.00%191M--0
Change In working capital 194.32%166M-1,392.86%-209M-42.07%-743M23.38%-770M-117.07%-57M42.11%-176M96.03%-14M23.31%-523M-186.32%-1.01B1,054.29%334M
-Change in receivables -1,000.00%-33M-52.00%-114M-32.56%-114M-8.18%-238M-68.18%-74M78.57%-3M21.88%-75M-30.30%-86M21.15%-220M70.27%-44M
-Change in inventory 72.77%-55M55.61%-95M32.97%-124M-105.61%-660M-28.26%-59M-112.63%-202M-197.22%-214M-71.30%-185M7.23%-321M-48.39%-46M
-Change in payables and accrued expense 1,294.12%237M-75.43%71M-113.27%-450M146.27%118M-93.13%23M112.06%17M456.79%289M42.66%-211M-162.50%-255M151.88%335M
-Change in other current assets 41.67%17M-407.14%-71M-34.15%-55M104.78%10M-40.45%53M122.22%12M86.54%-14M70.71%-41M-55.97%-209M709.09%89M
Cash from discontinued investing activities
Operating cash flow 43.55%1B23.56%813M-13.68%164M64.02%2.5B18.59%957M48.51%698M114.33%658M427.59%190M-18.40%1.53B68.83%807M
Investing cash flow
Cash flow from continuing investing activities -620.20%-1.43B67.62%-272M41.32%-284M-28.05%-2.58B-478.57%-1.05B11.21%-198M-2,609.68%-840M69.27%-484M-26.00%-2.01B60.52%-182M
Net PPE purchase and sale 5.29%-179M-8.39%-155M-64.81%-178M-22.74%-707M-27.14%-267M-26.85%-189M-37.50%-143M4.42%-108M-6.67%-576M19.85%-210M
Net intangibles purchase and sale -1,233.33%-120M-23.21%-69M-5,800.00%-59M-228.26%-59M-69.57%7M-200.00%-9M-429.41%-56M-111.11%-1M-87.26%46M-92.31%23M
Net business purchase and sale ---1.13B92.53%-48M87.47%-47M-17.83%-1.81B-15,960.00%-793M--0---643M74.51%-375M-7.33%-1.54B102.28%5M
Net investment purchase and sale --0---------96.43%2M--0--0--------273.33%56M--0
Net other investing changes -----------1M--1M--0--------------------
Cash from discontinued investing activities
Investing cash flow -624.37%-1.43B67.74%-271M41.12%-285M-28.00%-2.57B-475.41%-1.05B12.44%-197M-2,796.55%-840M69.25%-484M-25.92%-2.01B60.30%-183M
Financing cash flow
Cash flow from continuing financing activities -56.25%7M-44.19%24M2,373.91%1.57B100.91%5M650.00%15M108.00%16M112.57%43M-885.71%-69M-475.79%-547M125.00%2M
Net issuance payments of debt 153.66%22M--0--1.62B97.58%-4M--073.55%-41M152.86%37M--0---165M--0
Cash dividends paid --0--0--049.09%-28M--0--00.00%-14M0.00%-14M0.00%-55M0.00%-13M
Proceeds from stock option exercised by employees 27.40%93M-4.00%24M-84.62%2M51.81%126M0.00%15M28.07%73M400.00%25M116.67%13M38.33%83M150.00%15M
Net other financing activities -575.00%-108M--027.94%-49M78.35%-89M--081.61%-16M98.11%-5M-17.24%-68M-311.00%-411M0.00%-1M
Cash from discontinued financing activities
Financing cash flow -56.25%7M-44.19%24M2,373.91%1.57B100.91%5M1,400.00%15M108.04%16M112.50%43M-1,050.00%-69M-476.84%-548M112.50%1M
Net cash flow
Beginning cash position 393.87%3.06B227.13%2.5B-6.31%1.06B-48.06%1.13B127.77%1.13B35.37%620M44.23%763M-48.06%1.13B8.67%2.17B-76.98%497M
Current changes in cash -181.04%-419M505.00%567M498.90%1.45B93.51%-67M-112.94%-81M1,048.89%517M-115.38%-140M77.85%-363M-677.09%-1.03B6,160.00%626M
Effect of exchange rate changes 220.00%6M66.67%-1M---7M55.56%-4M33.33%4M16.67%-5M50.00%-3M--0-50.00%-9M400.00%3M
End cash Position 134.01%2.65B393.87%3.06B227.13%2.5B-6.31%1.06B-6.31%1.06B127.77%1.13B35.37%620M44.23%763M-48.06%1.13B-48.06%1.13B
Free cash flow 41.87%698M29.42%585M-217.39%-81M86.32%1.7B14.62%690M64.55%492M123.76%452M136.51%69M-30.55%914M183.96%602M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data